Skip to main content
SpringerLink
Log in

Psychological and Behavioral Therapies in Multiple Sclerosis

  • Chapter
Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases

Part of the book series: Neuropsychiatric Symptoms of Neurological Disease ((NSND))

  • 979 Accesses

Abstract

Depression in multiple sclerosis (MS) is very common, with a lifetime prevalence of around 50 %, which is much higher than the 8 % reported for the general population. In this chapter, we explore some of the psychological and behavioral depression treatments that have been studied in MS. Our review shows clearly that depression in MS is treatable, via both psychotherapeutic and behavioral interventions. Randomized clinical trials (RCTs) on psychotherapy have generally revealed very large effect sizes, with the one benchmarking study (one that examines treatment as it actually occurs in clinical settings) in the literature showing a still large but somewhat smaller effect size than RCTs. Exercise appears to be a promising potential treatment of depression in MS and has been shown to be correlated with lower depression. Additionally, RCTs of exercise have revealed small to moderate effect sizes on reducing depression. One problem with psychological and behavioral treatments of depression in MS is the salience of disability and travel issues that make involvement in such intensive treatment more challenging. Thus, even though treatments are often effective, patients may avoid them in favor of other interventions. Telephone-based interventions have been shown to be very effective in treating depression in MS and could represent a promising approach that circumvents such obstacles. Even though current treatments are effective, future research should explore why nearly half of patients do not respond to available treatments. A focus on the possibility that co-morbid conditions (e.g., anxiety or personality disorders) could interfere with standard depression treatments, as well as possible mediators of treatment (e.g., fatigue, disability levels, sleep disturbance), may be promising avenues for future research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IML, Eisen K, Paty DW. Depression and multiple sclerosis. Neurology. 1996;46:628–32.

    Article  CAS  PubMed  Google Scholar 

  2. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry. 2002;159:1862–8.

    Article  PubMed  Google Scholar 

  3. Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc. 2008;14:691–724.

    PubMed  Google Scholar 

  4. Ehde DM, Kraft GH, Chwastiak L, Sullivan MD, Gibbons LE, Bombardier CH, Wadhwani R. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis. Gen Hosp Psychiatry. 2008;30:40–8.

    Article  PubMed  Google Scholar 

  5. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol. 2001;69(6):1–8.

    Article  Google Scholar 

  6. Baron KG, Corden M, Jin L, Mohr DC. Impact of psychotherapy on insomnia symptoms in patients with depression and multiple sclerosis. J Behav Med. 2011;34:92–101.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Strober LB, Arnett PA. Assessment of depression in multiple sclerosis: development of a “trunk and branch” model. Clin Neuropsychol. 2010;24:1146–66.

    Article  CAS  PubMed  Google Scholar 

  8. Beck AT, Steer RA, Brown GK. BDI-FastScreen for medical patients manual. San Antonio: The Psychological Corporation; 2000.

    Google Scholar 

  9. Benedict RHB, Fishman I, McClellan MM, Bakshi R, Weinstock-Guttman B. Validity of the beck depression inventory – fast screen in multiple sclerosis. Mult Scler. 2003;9:393–6.

    Article  CAS  PubMed  Google Scholar 

  10. Strober LB, Arnett PA. Depression in multiple sclerosis: the utility of common self-report instruments and development of a disease-specific measure. J Clin Exp Neuropsychol (in revision).

    Google Scholar 

  11. Honarmand K, Feinstein A. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler. 2009;15:1518–24.

    Article  PubMed  Google Scholar 

  12. Benedict RHB, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, Weinstock-Guttman B. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci. 2005;231:29–34.

    Article  PubMed  Google Scholar 

  13. Bruce JM, Hancock LM, Arnett PA, Lynch S. Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition. J Behav Med. 2010;33:219–27.

    Article  PubMed  Google Scholar 

  14. Mohr DC, Goodkin DE. Treatment of depression in multiple sclerosis: review and meta-analysis. Clin Psychol Sci Practice. 1999;6(1):1–9.

    Article  Google Scholar 

  15. Mohr DC, Hart SL, Julian L, Catledge C, Honos-Webb L, Vella L, Tasch ET. Telephone-administered psychotherapy for depression. Arch Gen Psychiatry. 2005;62:1007–14.

    Article  PubMed  Google Scholar 

  16. Mohr DC, Likosky W, Bertagnolli A, Goodkin DE, Van Der Wende J, Dwyer P, Dick LP. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol. 2000;68(2):356–61.

    Article  CAS  PubMed  Google Scholar 

  17. Cooper CL, Hind D, Parry GD, Isaac CL, Dimairo M, O’Cathain A, Sharrack B. Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial. Trials. 2011;12:259.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Askey-Jones S, David AS, Silber E, Shawd P, Chalder T. Cognitive behaviour therapy for common mental disorders in people with multiple sclerosis: a bench marking study. Behav Res Ther. 2013;51:648–55.

    Article  CAS  PubMed  Google Scholar 

  19. Stanton BR, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler. 2006;12:481–6.

    Article  CAS  PubMed  Google Scholar 

  20. Rimer J, Dwan K, Lawlor DA, Greig CA, McMurdo M, Morley W, Mead GE. Exercise for depression. Cochrane Database Syst Rev. 2012;7.

    Google Scholar 

  21. Stroud NM, Minahan CL. The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis. Health Qual Life Outcomes. 2009;7:68.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Ensari I, Motl RW, McAuley E, Mullen SP, Feinstein A. Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis. Mult Scler. 2014;20:602–9.

    Article  PubMed  Google Scholar 

  23. Jensen MP, Molton IR, Gertz KJ, Bombardier CH, Rosenberg DE. Physical activity and depression in middle and older-aged adults with multiple sclerosis. Disabil Health J. 2012;5:269–76.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Suh Y, Motl RW, Mohr DC. Physical activity, disability, and mood in the early stage of multiple sclerosis. Disabil Health J. 2010;3(2):93–8.

    Article  PubMed  Google Scholar 

  25. Snook EM, Motl RW. Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabil Neural Repair. 2008;23(2):108–116.

    Google Scholar 

  26. Feinstein A, Rector N, Motl R. Exercising away the blues: can it help multiple sclerosis-related depression? Mult Scler. 2013;19:1815–9.

    Article  PubMed  Google Scholar 

  27. Ahmadi A, Arastoo AA, Nikbakht M, Zahednejad S, Rajabpour M. Comparison of the effects of 8 weeks aerobic and yoga training on ambulatory function, fatigue and mood status in MS patients. Iran Red Crescent Med J. 2013;15:449–54.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Briken S, Gold SM, Patra S, Vettorazzi E, Harbs D, Tallner A, Heesen C. Effects of exercise on fitness and cognition in progressive MS: a randomized controlled pilot trial. Mult Scler. 2014;20:382–90.

    Article  CAS  PubMed  Google Scholar 

  29. Bombardier CH, Ehde DM, Gibbons LE, Wadhwani R, Sullivan MD, Rosenberg DE. Telephone-based physical activity counseling for major depression in people with multiple sclerosis. J Consult Clin Psychol. 2013;81:89–99.

    Article  PubMed  Google Scholar 

  30. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interview: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71:843–61.

    Article  PubMed  Google Scholar 

  31. Paul L, Coulter EH, Miller L, McFadyen A, Dorfman J, Mattison PGG. Web-based physiotherapy for people moderately affected with multiple sclerosis; quantitative and qualitative data from a randomized controlled pilot study. Clin Rehabil. 2014;28:924–35.

    Article  PubMed  Google Scholar 

  32. Ashworth NL, Chad KE, Harrison EL, Reeder BA, Marshall SC. Home versus center based physical activity programs in older adults. Cochrane Database Syst Rev. 2005;25.

    Google Scholar 

  33. Romberg A, Virtanen A, Ruutiainen J. Long-term exercise improves functional impairment but not quality of life in multiple sclerosis. J Neurol. 2005;252:839–45.

    Article  PubMed  Google Scholar 

  34. Watson D. Intraindividual and interindividual analyses of positive and negative affect: their relation to health complaints, perceived stress, and daily activities. J Pers Soc Psychol. 1988;54:1020–30.

    Article  CAS  PubMed  Google Scholar 

  35. Kelsey KS, DeVellis BM, Begum M, Belton L, Hooten EG, Campbell MK. Positive affect, exercise, and self-reported health in blue collar women. Am J Health Behav. 2006;30:199–207.

    Article  PubMed  Google Scholar 

  36. Kratz AL, Ehde DM, Bombardier CH. Affective mediators of a physical activity intervention for depression in multiple sclerosis. Rehabil Psychol. 2014;59:57.

    Article  PubMed  Google Scholar 

  37. Suh Y, Motl RW, Mohr DC. Physical activity, social support, and depression: possible independent and indirect associations in persons with multiple sclerosis. Psychol Health Med. 2012;17(2):196–206.

    Article  PubMed  Google Scholar 

  38. MacAllister WS, Krupp LS. Multiple sclerosis-related fatigue. Phys Med Rehabil Clin N Am. 2005;16:483–502.

    Article  PubMed  Google Scholar 

  39. Roppolo M, Mulasso A, Gollin M, Bertolotto A, Ciairano S. The role of fatigue in the associations between exercise and psychological health in multiple sclerosis: direct and indirect effects. Ment Health Phys Act. 2013;6:87–94.

    Article  Google Scholar 

  40. Asano M, Duquette P, Andersen R, Lapierre Y, Mayo NE. Exercise barriers and preferences among women and men with multiple sclerosis. Disabil Rehabil. 2013;35(5):353–61.

    Article  PubMed  Google Scholar 

  41. Morrison JD, Stuifbergen AK. Outcome expectations and physical activity in persons with longstanding multiple sclerosis. J Neurosci Nurs. 2014;46(3):171–9.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychology, College of the Liberal Arts, Penn State University, 352 Bruce V. Moore Bldg., University Park, PA, 16802-3105, USA

    Peter A. Arnett Ph.D.

  2. Department of Psychology, Penn State University, 372 Moore Building, University Park, PA, 16802, USA

    Dede Ukueberuwa M.S. & Margaret Cadden B.S.

Authors
  1. Peter A. Arnett Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dede Ukueberuwa M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Margaret Cadden B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter A. Arnett Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Neurology, Centre Hospitalier Universitaire Pellegrin, INSERM U 862, Université de Bordeaux, Bordeaux, Gironde, France

    Bruno Brochet

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Arnett, P.A., Ukueberuwa, D., Cadden, M. (2015). Psychological and Behavioral Therapies in Multiple Sclerosis. In: Brochet, B. (eds) Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases. Neuropsychiatric Symptoms of Neurological Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-18464-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18464-7_12

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18463-0

  • Online ISBN: 978-3-319-18464-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation